Opus Genetics is trading 10.2% up now at $3.83 as the stock extends its late-July rally on strong trading momentum and positive sentiment, without fresh company-specific headlines.
- The move suggests traders are leaning into recent upside volatility rather than reacting to new fundamental news.
- The advance aligns with a broadly risk-on market backdrop, with major U.S. indices up more than 1%.